World Cervical Cancer Diagnostic Testing Market Analyzed in New In-Demand Research Report Available at MarketPublishers.com

New research report “Cervical Cancer Diagnostic Tests (Pap Smear, Colposcopy And Ecc Procedures) Market - Global Industry Analysis By Test Type And Age Group, Market Size, Share And Forecast, 2012 – 2018” elaborated by Transparency Market Research has been recently published by Market Publishers Ltd. The study states that the total Pap smear test market revenues exceeded USD 27.9 million last year.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
TD The Market Publishers Ltd

http://marketpublishers.com/

London, UK (PRWEB) November 02, 2012

The development of the cervical cancer diagnostic tests market is fuelled by technological advancements, the invention of new methods of testing, rapidly growing population, as well as the rising concerns over healthcare issues.

The market is segmented into Pap smear tests, colposcopy tests, and ECC procedures. The total Pap smear test market revenues exceeded USD 27.9 million last year and are expected to increase by 1.7% in six years. ECC procedures is the fastest growing segment. The USA, accounting for more than 30% of the world market share, is the largest local market. The countries of the Asia-Pacific region are likely to witness the highest market expansion.

New research report “Cervical Cancer Diagnostic Tests (Pap Smear, Colposcopy And Ecc Procedures) Market - Global Industry Analysis By Test Type And Age Group, Market Size, Share And Forecast, 2012 – 2018” elaborated by Transparency Market Research has been recently published by Market Publishers Ltd.

Report Details:

Title: Cervical Cancer Diagnostic Tests (Pap Smear, Colposcopy And Ecc Procedures) Market - Global Industry Analysis By Test Type And Age Group, Market Size, Share And Forecast, 2012 - 2018
Published: October, 2012
Pages:    124
Price:    US$ 4,595.00
http://marketpublishers.com/report/life_sciences/diagnostics-diseases/cervical-cancer-diagnostic-tests-pap-smear-colposcopy-n-ecc-procedures-market-global-industry-analysis-by-test-type-n-age-group-market-size.html

The research report highlights the cervical cancer diagnostic tests market by covering its main segments: Pap smear tests, colposcopy tests, and ECC procedures. It thoroughly analyzes the global industry by test type, age group, and by geography.

The study describes the dominant market players through a detailed study of their business strategies, financial performance, and recent developments. The market trends as well as drivers and restrains are examined in detail. The research also provides a guide to modern technological advancements and innovative test methods. In addition, the forecasts for the cervical cancer diagnostic tests market development are offered in the report.

Report Contents:

CHAPTER 1 PREFACE

1.1 REPORT DESCRIPTION
1.2 RESEARCH METHODOLOGY

CHAPTER 2 EXECUTIVE SUMMARY AND MARKET OVERVIEW

CHAPTER 3 CERVICAL CANCER DIAGNOSTIC TESTS MARKET ANALYSIS

3.1 MARKET TREND ANALYSIS BY TEST TYPES (USD THOUSANDS)
3.2 MARKET ATTRACTIVENESS – CERVICAL CANCER DIAGNOSTIC TESTS MARKET BY GEOGRAPHY
3.3 MARKET DYNAMICS
3.3.1 DRIVERS
    3.3.1.1 High Prevalence of HPV Infected Patients
    3.3.1.2 Rising Number of Female Smokers
    3.3.1.3 Rising Incidences of Teenage Sexual Encounters
    3.3.1.4 Rising obesity
    3.3.1.5 Increased Cancer Awareness Programs
    3.3.1.6 Rising Disposable Income of the Consumers
3.3.2 CERVICAL CANCER DIAGNOSTIC TESTS MARKET DRIVER IMPACT ANALYSIS
3.3.3 RESTRAINTS
    3.3.3.1 Government Regulations and Guidelines
    3.3.3.2 Alternative Cervical Cancer Diagnosis Method
    3.3.3.3 Lack of Appropriate Healthcare Infrastructure in Underdeveloped and Developing Countries
    3.3.3.4 HPV Vaccination
    3.3.3.5 Inaccuracy in Pap Smear Test Results
3.3.4 CERVICAL CANCER DIAGNOSTIC TESTS MARKET RESTRAINTS IMPACT ANALYSIS
3.3.5 OPPORTUNITY
    3.3.5.1 Technological advancements
     3.3.5.1.1 Technological advancements such as the invention of LBC(Liquid Based Cytology)
    3.3.5.2 Aging Global Population Especially in Europe, Japan and the U.S.
    3.3.5.3 Healthcare related developments in emerging economies
3.3.6 OPPORTUNITY IMPACT ANALYSIS FOR THE CERVICAL CANCER DIAGNOSTIC TESTS MARKET
3.4 MARKET SHARE BY KEY PLAYERS
3.5 PORTER’S FIVE FORCES ANALYSIS FOR THE CERVICAL CANCER DIAGNOSTIC TESTS MARKET

CHAPTER 4 CERVICAL CANCER DIAGNOSTIC TESTS MARKET BY TEST TYPES

4.1 CERVICAL CANCER DIAGNOSTIC TESTS MARKET BY TEST TYPES – INTRODUCTION
4.2 PAP SMEAR TESTS MARKET
4.2.1 GLOBAL - PAP SMEAR MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
4.2.2 GLOBAL - NUMBER OF PAP SMEAR TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
4.2.3 GLOBAL - NUMBER OF ABNORMAL PAP SMEAR TEST RESULTS, 2012 – 2018 (THOUSANDS)
4.3 COLPOSCOPY TESTS MARKET
4.3.1 GLOBAL - COLPOSCOPY MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
4.3.2 GLOBAL - NUMBER OF COLPOSCOPY TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
4.3.3 GLOBAL - NUMBER OF ABNORMAL COLPOSCOPY PROCEDURE TEST RESULTS, 2012 – 2018 (THOUSANDS)
4.4 ECC PROCEDURE MARKET
4.4.1 GLOBAL - ECC PROCEDURE MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
4.4.2 GLOBAL – NUMBER OF ECC PROCEDURES PERFORMED, 2012 – 2018 (THOUSANDS)

CHAPTER 5 CERVICAL CANCER DIAGNOSTIC TESTS MARKET BY GEOGRAPHY

5.1 OVERVIEW
5.2 U.S..
5.2.1 U.S. PAP SMEAR TESTS MARKET
5.2.2 U.S. - PAP SMEAR MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
5.2.3 U.S. - NUMBER OF PAP SMEAR TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
5.2.4 U.S. - NUMBER OF ABNORMAL PAP SMEAR TEST RESULTS, 2012 – 2018 (THOUSANDS)
5.2.5 U.S. COLPOSCOPY TESTS MARKET
5.2.6 U.S. - COLPOSCOPY MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
5.2.7 U.S. - NUMBER OF COLPOSCOPY TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
5.2.8 U.S. - NUMBER OF ABNORMAL COLPOSCOPY PROCEDURE TEST RESULTS, 2012 – 2018 (THOUSANDS)
5.2.9 U.S. ECC PROCEDURE MARKET
5.2.10 U.S. - ECC PROCEDURE MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
5.2.11 U.S. – NUMBER OF ECC PROCEDURES PERFORMED, 2012 – 2018 (THOUSANDS)
5.3 EUROPE
5.3.1 MARKET ANALYSIS FOR THE EUROPEAN PAP SMEAR TESTS MARKET
    5.3.1.1 Drivers
     5.3.1.1.1 European guidelines for quality assurance in cervical cancer diagnosis
    5.3.1.2 Restraints
    5.3.1.3 Opportunities
5.3.2 U.K
    5.3.2.1 U.K Pap Smear Tests Market
    5.3.2.2 U.K - Pap smear market by age group, 2012 – 2018 (USD thousands)
    5.3.2.3 U.K - number of Pap smear tests performed, 2012 – 2018 (thousands)
    5.3.2.4 U.K - number of abnormal Pap smear test results, 2012 – 2018 (thousands)
    5.3.2.5 U.K Colposcopy Tests Market
    5.3.2.6 U.K - Colposcopy market by age group, 2012 – 2018 (USD thousands)
    5.3.2.7 U.K - number of Colposcopy tests performed, 2012 – 2018 (thousands)
    5.3.2.8 U.K - number of abnormal Colposcopy procedure test results, 2012 – 2018 (thousands)
    5.3.2.9 U.K ECC Procedure Market
    5.3.2.10 U.K - ECC procedure market by age group, 2012 – 2018 (USD thousands)
    5.3.2.11 U.K – number of ECC procedures performed, 2012 – 2018 (thousands)
5.3.3 FRANCE
    5.3.3.1 France Pap Smear Tests Market
...

More new research reports by the publisher can be found at Transparency Market Research page.


Contact